DTL
BMRN icon

Dynamic Technology Lab’s BioMarin Pharmaceuticals BMRN Stock Holding History

Dynamic Technology Lab’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,376
Closed -$1.01M – 934
2024
Q3 		$1.01M Buy
+14,376
New +$1.2M 0.11% 325
2024
Q1 		– Sell
-8,345
Closed -$805K – 1056
2023
Q4 		$805K Buy
+8,345
New +$738K 0.09% 406
2023
Q3 		– Sell
-4,120
Closed -$357K – 969
2023
Q2 		$357K Buy
+4,120
New +$388K 0.05% 632
2023
Q1 		– Sell
-10,300
Closed -$1.07M – 1106
2022
Q4 		$1.07M Sell
10,300
-3,610
-26% -$339K 0.11% 315
2022
Q3 		$1.18M Buy
+13,910
New +$1.24M 0.12% 317
2022
Q2 		– Sell
-16,890
Closed -$1.3M – 1155
2022
Q1 		$1.3M Buy
+16,890
New +$1.41M 0.15% 192
2019
Q3 		– Sell
-11,300
Closed -$968K – 963
2019
Q2 		$968K Buy
11,300
+3,296
+41% +$282K 0.16% 182
2019
Q1 		$711K Buy
8,004
+4,739
+145% +$439K 0.12% 283
2018
Q4 		$278K Sell
3,265
-7,041
-68% -$670K 0.05% 673
2018
Q3 		$1M Buy
+10,306
New +$1.03M 0.14% 225
2018
Q1 		– Sell
-5,800
Closed -$517K – 1059
2017
Q4 		$517K Buy
5,800
+3,400
+142% +$296K 0.09% 410
2017
Q3 		$223K Sell
2,400
-1,651
-41% -$146K 0.04% 867
2017
Q2 		$368K Buy
+4,051
New +$369K 0.07% 578
2015
Q4 		– Sell
-4,000
Closed -$387K – 889
2015
Q3 		$387K Buy
+4,000
New +$534K 0.13% 293
2014
Q2 		– Sell
-3,139
Closed -$214K – 671
2014
Q1 		$214K Buy
+3,139
New +$231K 0.13% 413

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Dynamic Technology Lab's BMRN Position: Q4 2024 in Review

Dynamic Technology Lab sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2024, closing a stake of 14,376 shares — an estimated $1.01M sold.

Dynamic Technology Lab first reported a position in BMRN in Q1 2014 and held it in 15 quarters. The position peaked at $1.3M in Q1 2022. 543 funds tracked by Wall St. Rank hold BMRN as of Q4 2024.

  • Dynamic Technology Lab reported no remaining BioMarin Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 14,376 BioMarin Pharmaceuticals shares in Q4 2024, an estimated $1.01M.
  • Dynamic Technology Lab first reported a position in BioMarin Pharmaceuticals in Q1 2014 and held it in 15 quarters.
  • Dynamic Technology Lab's BioMarin Pharmaceuticals position peaked at $1.3M in Q1 2022.
  • 543 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.